U.S. Markets closed

Amarin Corporation plc (AMRN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.28+0.06 (+1.86%)
At close: 4:00PM EDT

3.22 0.00 (0.00%)
After hours: 4:00PM EDT

People also watch
ARNAACHNOREXGALEVVUS
Full screen
Previous Close3.22
Open3.20
Bid3.26 x 500
Ask3.31 x 1500
Day's Range3.20 - 3.31
52 Week Range2.64 - 4.47
Volume946,766
Avg. Volume2,674,545
Market Cap888.2M
Beta1.88
PE Ratio (TTM)-10.51
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube9 days ago

    ETFs with exposure to Amarin Corp. Plc : September 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube20 days ago

    ETFs with exposure to Amarin Corp. Plc : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube26 days ago

    Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Amarin Corp. Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Amarin Corp. Plc – Ionis Pharmaceuticals, Inc., AbbVie, Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Neptune Technologies & Bioressources Inc., Alkermes Plc and Astrazeneca ... Read more (Read more...)